NHS Framework Agreement, Branded Medicines for London and South of England
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- 1B
- Sector
- HEALTH
- Published
- 17 Sep 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London: Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
1 buyer
- NHS England Leeds
42 suppliers
- Drreddys Laboratories Beverley
- Accord Devon
- Techdow Pharma England Guildford
- Ul Global Pharma Hertfordshire
- Biogen Maidenhead
- Merck Sharpe & Dohme London
- Bayer Reading
- Napp Pharmaceuticals Cambridge
- Novo Nordisk Gatwick
- Daiichi Sankyo Uxbridge
- Teva Castleford
- Pfizer Kent
- Roche Products Garden City
- Mylan Barnet
- Sandoz Camberley
- Celltrion Healthcare Slough
- Merck Serono Feltham
- Bristol Myers Squibb Uxbridge
- Eli Lilly Basingstoke
- Takeda London
- Ferring Pharmaceuticals West Drayton
- Aventis Pharma Reading
- Tetris Pharma Northampton
- Ipsen Slough
- Profile Pharma Chichester
- CST Pharma Walsall
- Gilead Sciences Holborn
- Amgen Cambridge
- Thornton & Ross Huddersfield
- Zentiva Pharma London
- Gedeon Richter Maida Vale
- Janssen Cilag High Wycombe
- Organon Pharmaceuticals London
- Sobi Swedish Orphan Biovitrum Cambridgeshire
- Astrazeneca Luton
- Allergan Marlow
- Vifor Pharma London
- Merz Hemel Hempstead
- Pharmacosmos Reading
- Morningside Pharmaeuticals Northampton
- Chugai Chiswick
- Ucb Slough
Description
NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab.
Lot Division
1 | CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B
CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months |
2 | CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche
CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months |
3 | CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A
CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months |
4 | CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B
CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months |
5 | CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche
CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months |
6 | CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab
CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab |
Award Detail
1 | Drreddys Laboratories (Beverley)
|
2 | Accord (Devon)
|
3 | Techdow Pharma England (Guildford)
|
4 | Ul Global Pharma (Hertfordshire)
|
5 | Biogen (Maidenhead)
|
6 | Merck Sharpe & Dohme (London)
|
7 | Bayer (Reading)
|
8 | Napp Pharmaceuticals (Cambridge)
|
9 | Novo Nordisk (Gatwick)
|
10 | Daiichi Sankyo (Uxbridge)
|
11 | Teva (Castleford)
|
12 | Pfizer (Kent)
|
13 | Roche Products (Garden City)
|
14 | Mylan (Barnet)
|
15 | Sandoz (Camberley)
|
16 | Celltrion Healthcare (Slough)
|
17 | Merck Serono (Feltham)
|
18 | Bristol Myers Squibb (Uxbridge)
|
19 | Eli Lilly (Basingstoke)
|
20 | Takeda (London)
|
21 | Ferring Pharmaceuticals (West Drayton)
|
22 | Aventis Pharma (Reading)
|
23 | Tetris Pharma (Northampton)
|
24 | Ipsen (Slough)
|
25 | Profile Pharma (Chichester)
|
26 | CST Pharma (Walsall)
|
27 | Gilead Sciences (Holborn)
|
28 | Drreddys Laboratories (Beverley)
|
29 | Accord (Devon)
|
30 | Techdow Pharma England (Guildford)
|
31 | Ul Global Pharma (Hertfordshire)
|
32 | Biogen (Maidenhead)
|
33 | Merck Sharpe & Dohme (London)
|
34 | Bayer (Reading)
|
35 | Napp Pharmaceuticals (Cambridge)
|
36 | Novo Nordisk (Gatwick)
|
37 | Daiichi Sankyo (Uxbridge)
|
38 | Teva (Castleford)
|
39 | Pfizer (Kent)
|
40 | Roche Products (Garden City)
|
41 | Mylan (Barnet)
|
42 | Sandoz (Camberley)
|
43 | Celltrion Healthcare (Slough)
|
44 | Merck Serono (Feltham)
|
45 | Bristol Myers Squibb (Uxbridge)
|
46 | Eli Lilly (Basingstoke)
|
47 | Takeda (London)
|
48 | Ferring Pharmaceuticals (West Drayton)
|
49 | Aventis Pharma (Reading)
|
50 | Tetris Pharma (Northampton)
|
51 | Ipsen (Slough)
|
52 | Profile Pharma (Chichester)
|
53 | CST Pharma (Walsall)
|
54 | Gilead Sciences (Holborn)
|
55 | Accord (Devon)
|
56 | Amgen (Cambridge)
|
57 | Thornton & Ross (Huddersfield)
|
58 | Merck Sharpe & Dohme (London)
|
59 | Zentiva Pharma (London)
|
60 | Napp Pharmaceuticals (Cambridge)
|
61 | Gedeon Richter (Maida Vale)
|
62 | Teva (Castleford)
|
63 | Pfizer (Kent)
|
64 | Roche Products (Garden City)
|
65 | Janssen Cilag (High Wycombe)
|
66 | Organon Pharmaceuticals (London)
|
67 | Celltrion Healthcare (Slough)
|
68 | Sobi Swedish Orphan Biovitrum (Cambridgeshire)
|
69 | Bristol Myers Squibb (Uxbridge)
|
70 | Eli Lilly (Basingstoke)
|
71 | Takeda (London)
|
72 | Astrazeneca (Luton)
|
73 | Accord (Devon)
|
74 | Amgen (Cambridge)
|
75 | Napp Pharmaceuticals (Cambridge)
|
76 | Novo Nordisk (Gatwick)
|
77 | Teva (Castleford)
|
78 | Pfizer (Kent)
|
79 | Roche Products (Garden City)
|
80 | Janssen Cilag (High Wycombe)
|
81 | Allergan (Marlow)
|
82 | Sandoz (Camberley)
|
83 | Merck Serono (Feltham)
|
84 | Eli Lilly (Basingstoke)
|
85 | Vifor Pharma (London)
|
86 | Merz (Hemel Hempstead)
|
87 | Pharmacosmos (Reading)
|
88 | Ipsen (Slough)
|
89 | Morningside Pharmaeuticals (Northampton)
|
90 | Chugai (Chiswick)
|
91 | Thornton & Ross (Huddersfield)
|
92 | Zentiva Pharma (London)
|
93 | Pfizer (Kent)
|
94 | Roche Products (Garden City)
|
95 | Organon Pharmaceuticals (London)
|
96 | Accord (Devon)
|
97 | Amgen (Cambridge)
|
98 | Thornton & Ross (Huddersfield)
|
99 | Merck Sharpe & Dohme (London)
|
100 | Zentiva Pharma (London)
|
101 | Napp Pharmaceuticals (Cambridge)
|
102 | Gedeon Richter (Maida Vale)
|
103 | Teva (Castleford)
|
104 | Pfizer (Kent)
|
105 | Roche Products (Garden City)
|
106 | Janssen Cilag (High Wycombe)
|
107 | Organon Pharmaceuticals (London)
|
108 | Celltrion Healthcare (Slough)
|
109 | Sobi Swedish Orphan Biovitrum (Cambridgeshire)
|
110 | Bristol Myers Squibb (Uxbridge)
|
111 | Eli Lilly (Basingstoke)
|
112 | Takeda (London)
|
113 | Astrazeneca (Luton)
|
114 | Ucb (Slough)
|
Award Criteria
price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-02ac57
- FTS 023223-2021